Top Bar

Get in Touch Today

Chemotherapy Cuts Mesothelioma Survival Time for Some Patients

In Australia, researchers say that chemotherapy at the end of a mesothelioma patient’s life may do more harm than good. A team from the Asbestos Disease Research Institute in Rhodes, Australia studied the 147 pleural mesothelioma patients who had received compensation from the government’s Dust Diseases Board to determine the link between a variety of factors (age, gender, geographic location,...

View Article

3rd International Symposium on Lung-Sparing therapies for Malignant Pleural Mesothelioma Set for May 18

On Saturday, May 18, mesothelioma experts will convene in Santa Monica, California for the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. The symposium will be led by Dr. Robert B. Cameron, M.D., Director of the UCLA Mesothelioma Comprehensive Research Program, Chief of Thoracic Surgery at the West Los Angeles VA Medical Center and Scientific...

View Article

Potential for Early Detection of Mesothelioma Tumors

When it comes to mesothelioma treatment, early diagnosis is the key to an improved survival rate, increased treatment options, and an enhanced quality of life. While there is currently no reliable screening method for detecting the presence of mesothelioma before symptoms set in, scientists have found hope in a bioelectric process that may help them identify cells that are “likely to develop...

View Article

Six Arizona School Districts Fined for Asbestos Violations

On February 20, the Environmental Protection Agency (EPA) announced that six school districts in Arizona have been fined nearly $100,000 for violations of the federal Asbestos Hazard Emergency Response Act (AHERA). A report from CBS5-Arizona stated that up to 15,000 children attend the 25 Arizona schools that have been found not to comply with AHERA. At the end of 2011, inspectors reported...

View Article

New Study: EPP too Risky for Mesothelioma Patients, Pleurectomy with Chemo Better

In Belgium, two thoracic oncologists are calling for a new mesothelioma clinical trial to examine the effects of perioperative chemotherapy in conjunction with lung-sparing pleurectomy/decortication (P/D) surgery. Pleurectomy/decortication has been the surgery of choice for treating pleural mesothelioma since 2011, when the Mesothelioma and Radical Surgery (MARS) randomized feasibility study...

View Article